AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 261: E252-E256, 1991;
0193-1849/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow A corrigendum has been published
Right arrow A corrigendum has been published
Right arrow A corrigendum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, B. A.
Right arrow Articles by Epstein, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, B. A.
Right arrow Articles by Epstein, F. H.

AJP - Endocrinology and Metabolism, Vol 261, Issue 2 E252-E256, Copyright © 1991 by American Physiological Society

ARTICLES

Atrial natriuretic peptide suppresses osmostimulated vasopressin release in young and elderly humans

B. A. Clark, D. Elahi, L. Fish, M. McAloon-Dyke, K. Davis, K. L. Minaker and F. H. Epstein
Charles A. Dana Research Institute, Beth Israel Hospital, Department of Medicine, Boston, Massachusetts.

Atrial natriuretic peptide (ANP) may suppress vasopressin release, but the dynamics of this interaction as well as the influence of age have not been defined. We studied six or seven young (19-40 yr old) and seven elderly volunteers (65-83 yr old) under two circumstances: 1) after infusion of 5% saline (0.04 ml.kg-1.min-1) for 2 h and 2) after the same infusion given with simultaneous synthetic human ANP (0.05 micrograms.kg-1.min-1). Hypertonic saline alone produced a progressive rise in plasma vasopressin with increasing serum sodium. During hypertonic saline alone, vasopressin levels began to rise at an increment in serum sodium of 1.67 +/- 0.35 mM in the young and 1.43 +/- 0.32 mM in the elderly and rose linearly with increasing serum sodium. When ANP was infused with hypertonic saline (with peak ANP levels of approximately 1,000 pM), vasopressin levels began to rise at an increment in serum sodium of 4.43 +/- 0.67 mM in the young and 4.57 +/- 0.43 mM in the elderly (P less than 0.01 vs. saline alone). Furthermore, the vasopressin response for any given serum sodium was significantly reduced in both young and elderly subjects, resulting in a rightward displacement of the curve relating vasopressin response to sodium concentration (P less than 0.001). In conclusion, ANP not only suppresses vasopressin but raises the threshold for release of vasopressin in response to osmotic stimulation in both young and elderly individuals. High circulating ANP levels may be responsible in part for the suppression of vasopressin levels and water diuresis seen during states of volume expansion.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
N. S. Stachenfeld, C. Silva, D. L. Keefe, C. A. Kokoszka, and E. R. Nadel
Effects of oral contraceptives on body fluid regulation
J Appl Physiol, September 1, 1999; 87(3): 1016 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. S. Stachenfeld, L. Dipietro, S. F. Palter, and E. R. Nadel
Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R187 - R195.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online